114 related articles for article (PubMed ID: 3624455)
1. Antibodies not directed against the acetylcholine receptor in myasthenia gravis. An immunoblot study.
Zimmermann CW; Weiss G
J Neuroimmunol; 1987 Oct; 16(2):225-36. PubMed ID: 3624455
[TBL] [Abstract][Full Text] [Related]
2. A solid-phase enzyme immunoassay for anti-acetylcholine receptor antibody in myasthenia gravis patients.
Kobayashi N; Sugita H; Terada E; Ghoda A; Okudaira H; Ogita T; Miyamoto T
J Immunol Methods; 1984 Oct; 73(2):267-72. PubMed ID: 6386990
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine receptor antibody in myasthenia gravis: purification and characterization.
Lefvert AK; Bergström K
Scand J Immunol; 1978; 8(6):525-33. PubMed ID: 734356
[TBL] [Abstract][Full Text] [Related]
4. The immunopathology of myasthenia gravis.
Lennon VA
Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
[TBL] [Abstract][Full Text] [Related]
5. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
[TBL] [Abstract][Full Text] [Related]
6. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
7. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
[TBL] [Abstract][Full Text] [Related]
8. [Demonstration of acetylcholine receptor antibodies in the serum of myasthenia gravis patients applying affinity chromatographically purified human acetylcholine receptor preparations (author's transl)].
Kalies I; Kalden JR; Heinz F; Janzen RW; Lachenmayer L
Klin Wochenschr; 1979 Sep; 57(17):875-81. PubMed ID: 502355
[TBL] [Abstract][Full Text] [Related]
9. An enzyme-linked immunosorbent assay for antibodies against saline-soluble muscle components in myasthenia gravis.
Akazawa S; Furukawa S; Kamo I; Furukawa Y; Satoyoshi E; Hayashi K
J Immunol Methods; 1986 Nov; 94(1-2):161-7. PubMed ID: 3782808
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.
Mittag TW; Tormay A; Massa T
Mol Pharmacol; 1978 Jan; 14(1):60-8. PubMed ID: 625290
[No Abstract] [Full Text] [Related]
11. Antibodies to skeletal muscle in myasthenia gravis. Part 3. Relation with clinical course and therapy.
Kuks JB; Limburg PC; Horst G; Oosterhuis HJ
J Neurol Sci; 1993 Dec; 120(2):168-73. PubMed ID: 8138806
[TBL] [Abstract][Full Text] [Related]
12. Properties and serum levels of specific populations of anti-acetylcholine receptor antibodies in myasthenia gravis.
Fulpius BW; Lefvert AK; Cuénoud S; Mourey A
Ann N Y Acad Sci; 1981; 377():307-15. PubMed ID: 6951478
[No Abstract] [Full Text] [Related]
13. Acetylcholine receptor antibodies and anti-idiotypic antibodies produced in blood lymphocyte cultures from patients with myasthenia gravis.
Lefvert AK; Sundén H; Holm G
Scand J Immunol; 1986 Jun; 23(6):655-62. PubMed ID: 3715409
[TBL] [Abstract][Full Text] [Related]
14. The role of acetylcholine receptor antibodies in myasthenia gravis.
Appel SH; Elias SB; Chauvin P
Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
[TBL] [Abstract][Full Text] [Related]
15. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
[TBL] [Abstract][Full Text] [Related]
16. [Anti-acetylcholine and anti-receptor antibodies in myasthenia].
Lebrun-Grandie P; Souan ML; Geffard M; Dartigues JF; Mauricet B; Orgogozo JM
Presse Med; 1987 Oct; 16(32):1577-80. PubMed ID: 2958833
[TBL] [Abstract][Full Text] [Related]
17. [The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)].
Toyka KV; Becker T; Fateh-Moghadam A; Besinger UA; Brehm G; Neumeier D; Heininger K; Birnberger KL
Klin Wochenschr; 1979 Sep; 57(18):937-42. PubMed ID: 502359
[TBL] [Abstract][Full Text] [Related]
18. Binding properties and subclass distribution of anti-acetylcholine receptor antibodies in myasthenia gravis.
Lefvert AK; Cuénoud S; Fulpius BW
J Neuroimmunol; 1981 Mar; 1(1):125-35. PubMed ID: 6799544
[TBL] [Abstract][Full Text] [Related]
19. Effects of antibodies to Torpedo acetylcholine receptor on the acetylcholine receptor--ionic channel complex of Torpedo electroplax and rabbit intercostal muscle.
Eldefrawi ME; Copio DS; Hudson CS; Rash J; Mansour NA; Eldefrawi AT; Albuguergue EX
Exp Neurol; 1979 May; 64(2):428-44. PubMed ID: 428517
[No Abstract] [Full Text] [Related]
20. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
